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Abstract: Porous vaterite crystals of CaCO3 are extensively used for the fabrication of self-assembled
polymer-based microparticles (capsules, beads, etc.) utilized for drug delivery and controlled release.
The nature of the polymer used plays a crucial role and discovery of new perspective biopolymers
is essential to assemble microparticles with desired characteristics, such as biocompatibility,
drug loading efficiency/capacity, release rate, and stability. Glycoprotein mucin is tested here
as a good candidate to assemble the microparticles because of high charge due to sialic acids,
mucoadhesive properties, and a tendency to self-assemble, forming gels. Mucin loading into the
crystals via co-synthesis is twice as effective as via adsorption into preformed crystals. Desialylated
mucin has weaker binding to the crystals most probably due to electrostatic interactions between
sialic acids and calcium ions on the crystal surface. Improved loading of low-molecular-weight
inhibitor aprotinin into the mucin-containing crystals is demonstrated. Multilayer capsules
(mucin/protamine)3 have been made by the layer-by-layer self-assembly. Interestingly, the deposition
of single mucin layers (mucin/water)3 has also been proven, however, the capsules were unstable,
most probably due to additional (to hydrogen bonding) electrostatic interactions in the case of the
two polymers used. Finally, approaches to load biologically-active compounds (BACs) into the
mucin-containing microparticles are discussed.
Keywords: CaCO3; mucin; adsorption; co-synthesis; layer-by-layer; protamine; aprotinin
1. Introduction
The layer-by-layer (LbL) adsorption of oppositely-charged polymers (polyelectrolytes)
onto matrices of various nature are actively used for the immobilization of biologically-active
compounds (BACs) [1–4]. Bio-friendly loading of BACs into the vaterite CaCO3 crystals has been
shown to be effective for encapsulation of fragile BACs into polymer-based microparticles assembled
onto these sacrificial crystals [5–7]. The crystals coated by polymers can be eliminated in the presence of
chelating agents, such as EDTA (ethylenediaminetetraacetic acid) or citric acid, or at pH below neutral.
The following synthetic biopolymers have been utilized for the preparation of
biologically/medically-relevant microparticles: poly-L-lysine, poly-L-arginine, poly-L-glutamic
acid, and poly-L-aspartic acid [8]. Natural biopolymers and their derivatives have also been used:
sodium alginate, chitosan, pectin, gelatine, carrageenan, hyaluronic acid, chondroitin sulfate, dextran,
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and cellulose [8]. In general, natural polypeptides and polysaccharides are weak polyelectrolytes
and can adopt multiple conformations in response to changes in the solution pH and temperature.
The folding and unfolding of their chains is driven by a balance of a number of the internal interactions
(hydrogen bonds, hydrophobic, electrostatic, etc.), providing fascinating properties for microparticles
made of self-assembled natural biopolymers.
Nowadays one of the main research directions in microencapsulation through self-assembled
nano- and micro-particles is devoted to looking for new biopolymers providing the microparticles with
desired properties, such as biocompatibility, biodegradability, and mucoadhesiveness [9]. One of the
major challenges is to efficiently load and adjust a sustained release of BACs that are typically weakly
bound to polymer-based microparticles.
In the past decade an interest into mucins, mucoadhesive glycoproteins, has significantly
increased [10–15]. Mucins are the main components of mucous membranes in the gastrointestinal tract,
as well as nasal and oral mucous membranes. The mucins possess a function of a barrier for pathogens,
as well as drugs.
Mucins are large, extracellular glycoproteins with molecular weights ranging from 0.5 to
20 MDa. Membrane-bound and secreted mucins are both highly glycosylated [10]. They consist
of 80% carbohydrates: N-acetylgalactosamine, N-acetylglucosamine, fucose, galactose, and sialic acid
(N-acetylneuraminic acid), and traces of mannose and sulfate. The oligosaccharide chains are attached
to the hydroxyl side chains of serine and threonines in the protein core. They consist of 5–15 monomers,
exhibiting moderate branching. The protein core itself is arranged into distinct regions. The central
glycosylated region is comprised of multiple tandem repeats rich in serine, threonine, and proline
(STP repeats). At the amino and carboxy terminals, as well as between STP repeats, there are regions of
the second type with a small number of O-glycosylation and a few N-glycosylation sites. The content
of cysteine in these regions is more than 10% and it participates in disulfide bond formation with
subsequent dimerization and polymerization of the dimers to form multimers (Figure 1). Due to this
structure a number of various interactions are present in mucins including electrostatics, hydrophobic
interactions, and hydrogen bonding; these interactions largely define the properties of mucins [16].
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Conformation of mucin is affected by pH and ionic strength [17]. Formation of self-assembled
aggregates and gels is typical for mucins and is driven by the formation of S–S bonds and the
interpenetration of the end glucose chains of mucin molecules [18] These processes, however, strongly
depend on the source of mucin, purity, pH, and ionic strength [11,12,19].
Adsorption of mucin onto various solid surfaces has been reported, for instance onto hydrophilic
and hydrophobic silica [20]. Elipsometry measurements have shown that adsorption is more
pronounced at hydrophobic surfaces giving 1.2 and 3.8 mg of mucin per m2 of the hydrophilic
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and hydrophobic silica, respectively. Mucin can be strongly bound to 282 nm-sized nanoparticles
of polystyrene resulting in 2.2 mg of mucin per one m2 of the nanoparticles [21]. After binding the
nanoparticles were coated with 4–6 nm layer of mucin and possessed hydrophilic properties.
The negative charge of mucin at neutral and alkaline pH is due to the presence of sialic acids
(pKa = 2.6) located on the ends of the chains of a polysaccharide backbone [11]. Mucins from various
sources have been employed to assemble multilayers using the following polycations: polyallylamine
hydrochloride, poly-L-lysine, polyethylenimine, methylcellulose, chitosan, and lactoperoxidases
(Mw 78 kDa, pI 8.3) [20–26]. The thickness of the formed multilayers depends on pH and ionic strength.
Conformation of mucin molecules depends of the concentration of calcium ions [27–30]. Ca2+ ions
have an effect on mucin aggregation, viscosity, and permeation of a mucous membrane for BACs
and nanoparticles [28]. It is also known that Ca2+ has a significant influence on the formation of
gallstones [27,31]. At the same time, to the best of our knowledge, there are no reports devoted to the
interaction between mucin and the vaterite CaCO3 crystals.
This work aims at the development of new approaches for BAC microencapsulation based on the
vaterite CaCO3 crystals and mucin. Here the mucin from the porcine stomach has been used for the
naturally-derived mucin widely employed for research [11,25]. The porcine gastric mucin has been
shown to be structurally related to human gastric mucin [32] and is, therefore, a decent substitute of
human gastric mucin because of its high availability and reduced number of ethical issues required for
the research. Moreover, mucins derived from a stomach have a tendency for gelation in acidic medium
which may be important in order to form polymer-based microparticles when the CaCO3 crystals are
eliminated in acidic medium. In order to test the applicability of mucin for the microencapsulation
we focus on the following important aspects of the encapsulation process: (i) development of simple
and robust analytical approaches (with no use of radiolabels and fluorescent probes) to determine
native mucin in the presence of crystal and BACs; (ii) assessment of mucin loading into the crystals
and multilayer capsules prepared based on mucin; and (iii) analysis of aprotinin (model BAC poorly
loaded into the crystals [33,34]) encapsulation into the crystals in the presence of mucin.
2. Materials and Methods
Anhydrous calcium chloride, ≥93.0% (C1016), anhydrous sodium carbonate Na2CO3, ≥99.0%
(S7795), commercial mucin from porcine stomach, Type III, (m1778), bound sialic acid 0.5–1.5%,
protamine from salmon, fluorescein isothiocyanate isomer 1 (FITC), 2,4,6-trinitrobenzenesulfonic
acid (TNBS), N-acetylneuraminic acid from Escherichia coli, ethylenediaminetetraacetic acid (EDTA),
aprotinin, N-benzoyl-L-arginine ethyl ester (BAEE), gel filtration molecular weight markers kit MW
12–200 kDa (Sigma-Aldrich, St. Louis, MO, USA); trypsin from bovine pancreas (Fluka, Dresden,
Germany); 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB, Serva, Heidelberg, Germany); cysteine, >99.5%
(BioUltra Sigma-Aldrich, St. Louis, MO, USA); Sephadex G-200 (Pharmacia, Stockholm, Sweden) were
used. All chemicals for buffers were laboratory grade and purchased from Sigma–Aldrich (St. Louis,
MO, USA). Before use, mucin solutions were sonicated for 30 min using the ultrasonic bath (Elmasonic
S15H, Singen, Germany).
2.1. Analytical Determination of Mucin
The concentration of the glycoprotein mucin in solution was determined spectrophotometrically at
the wavelengths of 214 nm and 260 nm, as well as by Schiff’s method via measurements of adsorption
at 555 nm [35]. Analytical size exclusion chromatography in the Biofox 17 SEC 8 × 300 mm column
(Bio-Works, Uppsala, Sweden) has been used utilizing the Smartline chromatographic system (Knauer,
Berlin, Germany) in a solution of 0.15 M NaCl (Table S1). Preliminarily, the column was calibrated
using solutions of purified mucin with different concentrations (0.01–0.1 mg mL−1) and proteins
with different molecular weights (Figure S1, Table S1). A total of 0.2 mL of the mucin solution with
a concentrations of 0.01–1.0 mg mL−1 were used for the chromatography analysis at the elution rate of
0.5 mL min−1. Absorbance of the eluted solutions was measured using the UV detector at wavelengths
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of 214 nm and 260 nm. After that the maximum absorbance of the high-molecular weight fraction was
measured (the time of elution was 9.3–9.7 min).
2.2. Purification of Mucin via Chromatography
A total of 15–45 mL of the mucin solution (1–5 mg mL−1) was subjected to the column filled with
Sephadex G-200 (dimension 2.5 × 35 cm) using the chromatographic system Bio-Logic LP (Bio-Rad,
Hercules, CA, USA) in the solution of ammonia (pH of 9.0). The elution rate was 0.5 mL min−1,
collection time for one fraction of eluted solution 12 min. Absorbance was determined in the obtained
fractions at wavelengths of 214, 260, and 480 nm. The fractions containing mucin, as identified by
absorbance and specific determination by the Schiff’s method (wavelength 555 nm), were combined
and freeze-dried.
2.3. Synthesis of Mucin-FITC
Fifty milligrams of commercially available mucin was dissolved in 10 mL of 0.5 M carbonate
buffer with pH 9.0. One millilitre of FITC solution (1 mg mL−1) in dimethylformamide was added drop
by drop and the whole mixture was incubated for 24 h at 4 ◦C. The solution was chromatographed at
the column filled with Sephadex G-200, as described above (Figure S2). The molar modification degree
of the free amino groups in mucin-FITC was determined by titration with TNBS [36] and was found to
be 17 ± 2% relative to purified mucin.
2.4. Synthesis of Desialylated Mucin
Fifteen milligrams of commercially available mucin was dissolved in 50 mL of 0.01 M HCl and
incubated for 3 h at 80 ◦C. The solution was chromatographed at the column filled with Sephadex
G-200, as described above (Figure S3). The content of sialic acids, determined by Hess’s method [37]
using the calibration curve for N-acetylneuraminic acid, was found to be 2.30 ± 0.10, 1.80 ± 0.10,
and 0.41 ± 0.05% for commercial, purified, and desialylated mucin, respectively.
2.5. Mucin Loading into the CaCO3 Crystals by Adsorption
The CaCO3 crystals were formed according to the standard procedure [5] by mixing of equimolar
solutions of CaCl2 and Na2CO3. The formed crystals were washed twice with a pure water and dried
at 70 ◦C. Thirty milligrams of the dry CaCO3 crystals were mixed with 1.5 mL of 1 mg mL−1 mucin
solution. The suspension was agitated on a shaker for 30 min. The precipitate was separated by
centrifugation (2 min, 1000× g) followed by removal of the supernatant and washed twice with 1.5 mL
water. The content of mucin was analysed in the supernatant and the washing solutions.
Efficiency of mucin incorporation was calculated using the following equation:
η =
(c0 − ce)
c0
where η is efficiency of protein incorporation, and c0 and ce are the initial and equilibrium protein
concentrations, respectively (mg mL−1).
The amount of the loaded protein at equilibrium was calculated using the following equation:
qe =
(c0 − ce)·V
m
where qe is the adsorption capacity (mg g−1), c0 and ce are the initial and equilibrium protein
concentrations, respectively (mg mL−1); V is the volume (mL) of the protein solution; and m is
the mass (g) of CaCO3.
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2.6. Mucin and Aprotinin Loading into the CaCO3 Crystals by Co-Synthesis
Three millilitres of the solution containing 1.67 mg mL−1 mucin and/or 0.167 mg mL−1 aprotinin
were added to 1 mL of the solution 1 M CaCl2. The solution was stirred for 5 min (100 rpm), 1 mL of the
solution of 1M Na2CO3 was added and further stirred for an additional 45 s. Then the suspension was
incubated for 15 min. The precipitate was separated by centrifugation (2 min, 1000× g) and washed
twice with 5 mL of water. If necessary, the particles were dried. The mass of the precipitate was
determined, and the mass of CaCO3 was calculated assuming the complete process of crystallization
of the insoluble crystals. The concentrations of mucin were determined in the supernatant and
washing solutions and, if necessary, the activity of aprotinin was also determined. The concentration
of active aprotinin in the solutions was determined by inhibition of trypsin using BAEE substrate as
described in [34,38].
2.7. Preparation of Polyelectrolyte Microcapsules
The LbL deposition of either mucin (control experiment) or mucin and protamine (a pair of
polymers used) has been performed on the synthetized CaCO3 crystals containing glycoprotein mucin
preloaded by co-synthesis. In either case, the polymer concentration was 0.5 mg mL−1 and the crystals
concentration was 20 mg mL−1. The coated crystals were washed twice with water and their ζ-potential
was measured after each adsorption step. The CaCO3 matrix in the prepared particles coated with
three mucin-protamine bilayers was dissolved by dropwise addition of an equimolar amount of 0.2 M
EDTA (to solubilize all the crystals), and then the formed polyelectrolyte capsules were washed three
times with water. The content of mucin in the microcapsules was determined by the analysis of its
content in solutions obtained during the capsule preparation procedure.
2.8. Characterisation of the Crystals and Microcapsules
Analysis of microparticles prepared in this study was carried out using optical microscopy
(Carl Zeiss, Jena, Germany), scanning electron microscopy (SEM, Zeiss DSM 40, Jena, Germany),
and fluorescence microscopy (EVOS FL, Thermo Fisher Scientific, Waltham, MA, USA). Determination
of the hydrodynamic diameter of commercial mucin (0.1 mg mL−1) was carried out using DLS (Malvern
Zetasizer Nano ZS, Malvern, UK) and nanoparticle tracking analysis (NTA, Malvern NanoSight NS500,
Malvern, UK). A suspension of microparticles (0.5 mg mL−1), and solutions of 0.1 mg mL−1 mucin or
protamine were used for the analysis of the ζ-potential (ZP) using DLS.
3. Results and Discussion
3.1. Analysis of Mucin Purity via Permeation Gel Chromatography
The first step in this study was to develop an effective approach to determine mucin concentration
in alkaline media (pH 7–10) and in the presence of BAC such as proteins and peptides. This is necessary
because the CaCO3 crystals dispersed in water provide the alkaline pH due to hydrolysis of the CaCO3.
The classical way to determine mucin is based on Schiff’s method [35]. OH groups of mucin
are oxidised by periodic acid to aldehydes (Figure S4). Our results indicate that pH of the analysed
solution has a significant effect on the purple-violet colour of solutions (A555) obtained using this
staining method (Figure S5). Thus, this method has been found as not useful for the determination of
mucin concentration at alkaline pH.
A number of reports have identified some protein-based low-molecular-weight impurities in
commercial samples of mucin [11,13,15,39]. Absorbance spectra of mucin used in this study show the
presence of two well-defined peaks at 214 and 216 nm as shown in the Figure 2, line 1.
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Figure 2. Absorption spectra of commercial (black line 1) and purified (red line 2) 0.1 mg mL−1 mucin.
Analytical size exclusion chromatography has been employed for further analysis of commercial
mucin revealing the presence of two fractions: low- and high-molecular-weight fractions (Figure 3,
line 1). Only the high-molecular-weight fraction had absorption at both 214 and 260 nm and gave
a specific staining by Schiff’s method. Another fraction (6–30 kDa) significantly contributed to the
absorption at 260 nm is most probably the low-molecular-weight impurity of a protein nature.
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Figure 4. Elution profile obtained by gel filtration on Sephadex G-200 of commercial mucin.
Further, the purified mucin has been used for the construction of calibration lines in order
to determine glycoproteins in this study. Based on the results of gel-permeation chromatography,
the content of glycoprotein in the commercial mucin has been found to be 87 ± 3% that is in line with
results obtained using the Schiff’s method (content is 84 ± 2%).
3.2. Loading of Mucin into CaCO3 Crystals (Adsorption and Co-Synthesis)
Loading of mucin into the crystals has been achieved via two methods, namely adsorption (mucin
is adsorbed into performed crystals) or co-synthesis (mucin is trapped in the crystals during crystal
synthesis). Figure 5 shows the schematics of the approaches used. Of note, the conditions of mucin
loading have been kept identical for both loading methods, such as the same time of exposure of
mucin to the crystals (15 min), the same final crystal and mucin concentrations (20 and 1 mg mL−1,
respectively), etc. This gives an option to compare the methods.
Optical and SEM microscopies did not reveal significant differences in morphology and size
(3–5 µm) of the crystals before and after mucin loading (Figure 6). This may be related to the rather
low concentration of mucin used. We believe that analysis of the surface of the crystals is sufficient
to conclude about the crystal internal structure change. This is because we have found (by atomic
force microscopy (AFM) measurements and other relevant techniques) that there is direct correlation
between the size of nanocrystallines on the surface of the crystals and those in the internal volume [40].
It would be of interest to analyse the morphology of the crystals using AFM in the future in order to
get more insights into the internal structure of the crystals. In this work we use optical microscopy
and SEM images for identification of the polymorph form of the crystals since the vaterite form has
a typical spherical shape, compared to cubic calcite. The same crystals, as obtained in this study,
have been previously analysed by X-ray diffraction analysis (XRD) revealing the vaterite form [40].
In the future we plan to utilize XRD as a powerful tool to analyse the structure of the crystals loaded
with substantial amounts of mucin under various conditions. This will open a way to probe the effect
of the preparation conditions on the crystal structure.
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solutions obtained during the mucin loading procedure (Table 1). Loading by co-synthesis resulted 
in almost twice higher content of mucin in the crystals. Moreover, mucin loaded by co-synthesis has, 
to a higher extent, been retained in the crystals during crystal washing with water. These results 
corroborate well with findings reported for proteins [33] showing the same trend. Based on the 
surface area of CaCO3 crystals obtained using the same procedure as in this study (8.8 m2 g−1 [41]) the 
mucin adsorption per a unit surface area of the crystals can be calculated. This value has been found 
to be 1.25 mg m−2, which is similar to mucin adsorption onto SiO2, which gives 1.2 mg m−2 [21]. Better 
understanding of the effect of the hydrophobicity of the surface of the crystals and limitations for 
Figure 5. Schematics of formulation of microparticles (crystals and polymer capsules) using mucin:
I–CaCO3 crystals; II–the crystals with mucin loaded by adsorption (a) or co-synthesis (b); III–crystals
coated with three layer of oppositely charged protamine and mucin; IV–polymer-based microcapsules
obtained after dissolution of the coated crystals using EDTA. Green arrows indicate a step of
introduction of a BAC to be further encapsulated into the microparticles.
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co-synthetized ucin (b,c).
Loading effici ncy for mucin loading to the crystals and the amount of mucin released from the
crystals during washing with water have been worked out by analysis of supernatants of solutions
obtained during the mucin loading procedure (Table 1). Loading by co-synthesis resulted in almost
twice higher content of mucin in the crystals. Moreover, mucin loaded by co-synthesis has, to a higher
extent, been retained in the crystals during crystal washing with water. These results corroborate well
with findings reported for proteins [33] showing the same trend. Based on the surface area of CaCO3
crystals obtained using the same procedure as in this study (8.8 m2 g−1 [41]) the mucin adsorption
per a unit surface area of the crystals can be calculated. This value has been found to be 1.25 mg m−2,
which is similar to mucin adsorption onto SiO2, which gives 1.2 mg m−2 [21]. Better understanding
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of the effect of the hydrophobicity of the surface of the crystals and limitations for mucin diffusion
through the pores of the crystals onto the loading amount can be realised in our future work.
Table 1. Characteristics of the incorporation of commercial mucin (1 mg mL−1) into the CaCO3 crystals
(20 mg mL−1).
Loading Method
Efficiency of Mucin Loading, % Release after Washing,
% of Loaded ZP, mVSpectrophotometry Analytical Chromatography
Adsorption 12 ± 2 10 ± 1 11 ± 1 −(15 ± 3)
Co-synthesis 22 ± 3 18 ± 2 5 ± 1 −(11 ± 2)
Further, we have analysed an average hydrodynamics diameter of mucin in water solution
(1 mg mL−1). DLS has revealed two populations of molecules of sizes 40 and 250 nm, respectively.
This is in a line with results obtained for commercial mucin from other sources [19]. The fraction with
larger size was diminished as a result of ultrasound treatment, dilution of mucin solution, increase of
pH (Figure S6). Both fractions are characterized by a negative value of the zeta potential (−15 mV).
We believe that the fraction with the larger size (250 nm) corresponds to the aggregated mucin and the
smaller fraction (40 nm) belongs most probably to single mucin molecules.
Literature reports indicate that intermolecular interaction between mucin molecules can be
enhanced in the presence of Ca2+ [28] and hydrodynamic radius of mucin in the solution of CaCl2 is
reduced compared to that in water [29]. We hypothesize that the smaller fraction of mucin molecules
(single mucin molecules) can diffuse through pores of the crystals (pore size in the range 5–40 nm [42]
and the larger fraction would be located presumably on the crystal surface. This may be valid for both
methods of mucin loading into the crystal, i.e., adsorption and co-synthesis. In order to prove this
assumption, we have analysed the mucin distribution in the crystals using fluorescence microscopy
and mucin-FITC (Figure 7). The results demonstrate that mucin is predominately located on edges of
the crystals and partially penetrates inside the crystal pores, which supports the assumption above.
In the previous work we have found that 70 kDa poly(sodium 4-styrenesulfonate) and poly(allylamine
hydrochloride) do not permeate well through pores of the crystals made at 22 ◦C (same protocol as for
the crystals prepared in this study) [40]. These polymers are supposed to have smaller size than 40 nm
(the small fraction of mucin identified as mentioned above). However, multiple adsorption of these
synthetic polymers by the LbL manner and their high charge may limit their diffusion into the crystals.
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CaCO3) after incubation with mucin-FITC (1 mg mL−1) for 15 in; and (c)-fluorescence profiles taken
along the yellow lines 1 and 2 across the particles in the image (b).
Loading of desialylated mucin into the CaCO3 crystals has been investigated in order to probe
an effect of sialic acids. The loading efficiency of the desialylated mucin was found to be 33 and
36% lower compared to that for the loading of commercial mucin using adsorption and co-synthesis,
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respectively. At the same time, the loss of mucin during washing in water increased by 10–15% for
either loading approaches. Thus, we can conclude that the presence of sialic acids in mucin most
probably improves the loading and retention of mucin in crystals, which can be explained by the
interaction of the acids with Ca2+ provided from the crystals. Binding of desialylated mucin with the
crystals can be driven by the interaction of Ca2+ with the protein-based part of mucin [29].
3.3. Encapsulation of Aprotinin into Mucin-Containing CaCO3 Crystals
Low-molecular-weight protein aprotinin (MW 6.5 kDa, pI 10.5) is an inhibitor of proteolytic
enzymes and is actively used as a medicine [43]. It has recently been shown [33,34]
that positively-charged aprotinin does not lose its biological activity in the presence of the CaCO3
crystals. However, its loading into the crystals by adsorption or co-synthesis is rather low compared to
other proteins, such as insulin and catalase; moreover, the retention of aprotinin in the crystals is not
high in washing steps with water.
We have further tested whether aprotinin loading into the crystals can be improved via co-loading
of mucin into the crystals. Co-loading of mucin resulted in an increase of aprotinin content by a factor
of three, giving a high content of aprotinin in the crystals of 1.5 ± 0.2 mg g−1 after two washing
steps with water. We believe that the formation of inter-polyelectrolyte complex between mucin and
aprotinin is a reason of better retention of aprotinin in the formed hybrid crystals.
3.4. Mucin-Containing Polymer Multilayer Capsules
In this part of the work we have considered an option to utilize mucin for the formulation of
multilayer capsules made of mucin and protamine as oppositely-charged bio-polymers. For this,
mucin-containing crystals were coated by mucin and protamine layers in the LbL manner. The peptide
protamine (5 kDa, pI 10.5) [44] has been previously used as a polycation [34,45] and, similar to
aprotinin, it did not show high affinity to the CaCO3 crystals [33]. The zeta potential of protamine
in water has been found to be +(7 ± 3) mV. During the LbL polymer deposition onto the crystal,
the Zeta potential of the coated crystals has been reversed from negative values (mucin deposition)
to positive ones (protamine deposition), as shown in Figure 8b. This proves the formation of the
mucin-protamine complex upon the coating procedure. Protamine has absorption maxima at 214 nm
and this is why the inclusion of mucin into the crystals has been determined using gel-permeation
chromatography. Protamine adsorption resulted in the removal of a part of previously-deposited
mucin (Figure 8a). However, the trend of the bio-polymer deposition demonstrated an increase of
a total amount of the adsorbed polymers as a whole. The deposition process is most probably driven
by the formation of both electrostatic interactions between the polymers and hydrogen bonding as well.
The similar deposition behaviour has been reported for bovine submaxillary mucin in combination
with polyallylamine hydrochloride [23] or lactoperoxidase [20].
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Figure 8. The content of mucin (a) and the zeta potential (b) of mucin-containing crystals (n = 1)
as a function of a number of deposition steps of either mucin or water (control) or mucin and protamine
pairs. The adsorption of mucin is indicated with a red colour.
Deposition of one polymer, namely mucin, has been used as a control experiment (Figure 8).
In this case, the crystals have been incubated stepwise in mucin solution and in water. The deposited
sequence can be shown as CaCO3(mucin)3 since the incubation in water is typically used as
an intermediate step between the deposition of polymers to wash out weakly-adsorbed polymer
molecules. The zeta potential of the coated particles has not been changed with an increase of the
number of deposited layers of mucin (Figure 8b). At the same time, the total amount of adsorbed
mucin has been increased with each deposition layer (Figure 8a). This is most probably due to
adsorption of more than one layer of mucin. The Ellman method [46] did not reveal any free
SH-groups in the commercial mucin sample, meaning that disulphide bonds cannot be responsible for
intermolecular interactions between the mucin molecules. It is of note that an amount of adsorbed
mucin in the controlled experiment was slightly lower than that for the mucin-protamine coating
(Figure 8a). This stimulated us to hypothesize that the mucin-protamine interactions are driven by
both electrostatics and hydrogen bonding (Figure 1) and the sequential deposition of only mucin
(control experiment) takes place due to only hydrogen bonding allowing the deposition of multiple
layers of only mucin. In future research, in order to probe the hydrogen bonding, we plan to prepare
the crystals with higher mucin content and utilize Fourier-transform infrared (FTIR) spectroscopy as
a convenient way of analysing mucin [47]. In this work, the rather low loading concentration of mucin
limits us for FTIR study.
The coated crystals CaCO3(mucin-protamine)3 and CaCO3(mucin)3 crystals-were stable upon
storage in water at 4 ◦C for a month without any sign of recrystallization (Figure 9 and Figure S7).
The presence of 0.2M EDTA resulted in dissolution of the carbonate crystals followed by formation
of stable (mucin-protamine)3 capsules (Figure 9b). At the same time, stable capsules solely made of
mucin have not been formed. This confirms that electrostatic interactions play a crucial role in the
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formation of stable multilayers and may be the contribution of electrostatics is stronger than that of
hydrogen bonds, stressing the dominating role of electrostatics.Micromachines 2018, 9, x FOR PEER REVIEW  12 of 16 
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The CaCO3 crystals contain mucin loaded by co-synthesis.
3.5. BAC Loading into Mucin-Containing Microparticles
Based on the results obtained using proteins (protamine, aprotinin), one can expect that the
mucin-containing particles may be effective for loading of BAC, in particular small-molecular-weight
and positively charged BACs that are difficult to load in substantial amounts. A rationality for the
loading of such BACs should be driven by the nature and a charge of the components (Figure 2,
indicated by green arrows). One can expect three main methods to load BACs: (i) via adsorption or
co-synthesis into the crystals together with mucin; (ii) as polycations during sequential deposition of
multilayers; and (iii) post-loading into preformed mucin-containing polymer capsules. The presence
of mucin in the CaCO3 crystals or multilayer capsules makes the crystals and capsules extremely
attractive for mucoadhesive delivery of BACs through a mucous membrane [15,48–50]. In regards
to this, the LbL assembly will provide a strong tool for introduction of various components into the
assembled structures in order to tune a function of the finally-assembled structure. Novel approaches
to probe diffusion into the formed multilayers are essential to understand and control a structure of
the assemblies and release characteristics of BACs from the assembled structures [51,52].
We believe that the approaches demonstrated here for assembly of mucin-containing
polymer-based microparticles can be further used for the design of composite multifunctional micro-
and nano-particles with required applications. For instance, introduction of the protein-repelling
agent polyethylene glycol into the particles by the approaches developed earlier [53,54] may reduce
protein-binding to the particles if undesired. Loading of a thermo-sensitive polymer, such as
poly(N-isopropilacrylamide), can give an option to assemble particles able to change their size and
hydrophobicity upon the temperature increase at physiologically-relevant conditions [55]. Utilization
of mucin-containing CaCO3 crystals for fabrication of porous self-assembled alginate hydrogels [56–58]
may be beneficial to design the hydrogels for the engineering of tissue having contact with mucosa.
New perspectives are open to assemble mucin-containing particles of various shapes via hard
templating onto protein aggregates as demonstrated earlier [59–62]. This approach may further
be considered in our upcoming study.
4. Conclusions
This study demonstrated the development of novel approaches for encapsulation of mucin into
self-assembled microstructures, i.e., polymer-based microparticles templated onto vaterite CaCO3
crystals. The following analytical methods for determination of mucin in alkaline solutions and
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in the presence of the crystals and proteins have been adopted: spectrophotometrical analysis of
adsorption at 214 nm and analytical permeation chromatography using a Biofox 17 SEC column.
The analytical methods used demonstrated the presence of protein-based low-molecular-weight
fraction in commercial mucin samples that had been removed to obtain purified mucin for further use.
Loading of mucin into the crystals by co-synthesis has been shown to be more effective than
the loading by adsorption (the loading capacity 11 and 6 mg of mucin per gram of the crystals,
respectively). Mucin can aggregate in water solution giving aggregates with a hydrodynamic diameter
of a few hundreds of nm, the diameter of single mucin molecules (in equilibrium with the aggregates)
is around 40 nm. As proven by optical fluorescence imaging and DLS mucin molecules can adsorb
onto and diffuse into the porous crystals that have pore size of the same dimensions (pores are in
the range 20–60 nm). Most probably the bulky and highly hydrated mucins are able to squeeze out
through the pores. Interestingly, desialylated mucin demonstrated weaker binding to the crystals that
can be explained by an enhancement of the binding via the interaction of calcium ions with sialic acids
present in the mucin backbone. Moreover, the presence of the sialic acids improved retention of mucin
in the crystals upon water washings.
Loading of mucin into performed CaCO3 crystals can be achieved via LbL deposition of a single
mucin or mucin-protamine pair, as proven by monitoring of the zeta potential and the amount of
deposited compounds. Stable multilayer capsules can, however, be formed after crystal elimination by
EDTA only for mucin-protamine pairs. This can be explained by additional electrostatic interactions for
the pair compared to only hydrogen bonding in the case of mucin deposition as a single component.
Successful inclusion of BACs into mucin-containing microparticles is demonstrated for aprotinin
as an important protease inhibitor. Finally, approaches for BAC loading are discussed in regards to the
encapsulation strategy proposed based on the CaCO3 crystal. The results of this study may open new
perspectives to utilize mucin as an important mucoadhesive polymer for effective encapsulation of
various compounds, including BACs.
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tested media on the determination of mucin by the Schiff method; Figure S6. Typical hydrodynamic diameter
distribution for commercial mucin (1 mg mL−1, H2O, 250 ◦C); Figure S7. Optical microscopy images of vaterite
crystals before (a) and (b) after coating with (mucin)3; Table S1. Calibration curves used in the work.
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